Psoriasis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Psoriasis stocks.

Psoriasis Stocks Recent News

Date Stock Title
Apr 27 ABBV 3 Dividend Stocks to Buy and Hold for the Next Decade
Apr 27 ABBV AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
Apr 27 ABBV Q1 2024 AbbVie Inc Earnings Call
Apr 26 ABBV Abbvie stock falls amid growing biosimilar competition
Apr 26 ABBV Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Apr 26 ABBV AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Apr 26 ABBV AbbVie stock slides 6% amid concerns about falling Humira sales
Apr 26 ABBV Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
Apr 26 INCY Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade)
Apr 26 ABBV AbbVie Inc. (ABBV) Q1 2024 Earnings Call Transcript
Apr 26 ABBV AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Apr 26 ABBV AbbVie's Q1: Positive Surprise
Apr 26 ABBV AbbVie Q1 report beats Street despite plunging Humira sales
Apr 26 ABBV Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Apr 26 ABBV PCE/Core PCE Numbers Came In Line With Expectations
Apr 26 ABBV AbbVie off 3% despite quarterly beats, 2024 guidance raise
Apr 26 ABBV PCE In-Line to Warmer, Pre-Market Calms; ABBV Beats, XOM Misses
Apr 26 ABBV AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Apr 26 ABBV AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Apr 26 ABBV Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
Psoriasis

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly. On people with darker skin the patches may be purple in colour. Psoriasis varies in severity from small, localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90 percent of cases. It typically presents as red patches with white scales on top. Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis presents as small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash becomes very widespread, and can develop from any of the other types. Fingernails and toenails are affected in most people with psoriasis at some point in time. This may include pits in the nails or changes in nail color.Psoriasis is generally thought to be a genetic disease that is triggered by environmental factors. In twin studies, identical twins are three times more likely to be affected compared to non-identical twins. This suggests that genetic factors predispose to psoriasis. Symptoms often worsen during winter and with certain medications, such as beta blockers or NSAIDs. Infections and psychological stress can also play a role. Psoriasis is not contagious. The underlying mechanism involves the immune system reacting to skin cells. Diagnosis is typically based on the signs and symptoms.There is no cure for psoriasis; however, various treatments can help control the symptoms. These treatments include steroid creams, vitamin D3 cream, ultraviolet light and immune system suppressing medications, such as methotrexate. About 75 percent of cases can be managed with creams alone. The disease affects two to four percent of the population. Men and women are affected with equal frequency. The disease may begin at any age, but typically starts in adulthood. Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, Crohn's disease and depression. Psoriatic arthritis affects up to 30 percent of individuals with psoriasis.

Browse All Tags